ganglioside
Commercial- Indications
- Nerve damage, Brain stroke
Company intelligence / Profile preview
Harbin Yida Pharmaceutical is an active pharmaceutical manufacturing company based in Harbin, China. It operates as part of the broader Harbin Pharmaceutical Group Co., Ltd. ("Hayao"), which develops and manufactures a wide range of pharmaceutical products including antibiotics, OTC medicines, traditional Chinese medicine preparations, biomedicines, nutritional supplements, and animal vaccines. The group has over a hundred commercialized drugs with more than twenty ongoing clinical trials across various therapeutic areas. No detailed clinical results are published specifically for the "Harbin Yida" entity.
4 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Harbin Yida Pharmaceutical.